基本信息
浏览量:1
职业迁徙
个人简介
Clinical Research Areas: Liver cancer surgery and melanoma surgery.
Laboratory Research Areas: 1) Viral oncolysis/gene therapy; 2) hepatocellular transformation.
One laboratory research focus is on viral oncolysis of solid tumors. We have examined Herpes simplex virus 1 immediately early gene regulation as a strategy to achieve preferential HSV-1 replication in transformed cells compared to normal cells. We are also involved in integration of specific therapeutic transgenes into these viral mutants. The laboratory work centers on genetic engineering of viral mutants, preclinical characterization, and clinical trials of viral oncolytic gene therapy.
A second laboratory research focus is on pathways involved in hepatocellular transformation to hepatocellular carcinoma (HCC) in the setting of cirrhosis. Recent studies on the EGF gene demonstrate a functional single nucleotide polymorphism that increases serum and liver EGF levels and significantly raises risk for HCC. Prevention of HCC by blockade of EGFR signalling can prevent HCC in preclinical models.
Laboratory Research Areas: 1) Viral oncolysis/gene therapy; 2) hepatocellular transformation.
One laboratory research focus is on viral oncolysis of solid tumors. We have examined Herpes simplex virus 1 immediately early gene regulation as a strategy to achieve preferential HSV-1 replication in transformed cells compared to normal cells. We are also involved in integration of specific therapeutic transgenes into these viral mutants. The laboratory work centers on genetic engineering of viral mutants, preclinical characterization, and clinical trials of viral oncolytic gene therapy.
A second laboratory research focus is on pathways involved in hepatocellular transformation to hepatocellular carcinoma (HCC) in the setting of cirrhosis. Recent studies on the EGF gene demonstrate a functional single nucleotide polymorphism that increases serum and liver EGF levels and significantly raises risk for HCC. Prevention of HCC by blockade of EGFR signalling can prevent HCC in preclinical models.
研究兴趣
论文共 496 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shadi A. Esfahani, Hua Ma, Shriya Krishna,Sergey Shuvaev, Arvin Hajmirzaian,Iris Zhou,Ciprian Catana,Mozhdeh Sojoodi,Eric Abston,David Ting,Pedram Heidari,Michael Lanuti,
CANCER RESEARCHno. 2 (2024)
Kenneth K. Tanabe,David Zahrieh,Carrie A. Strand,Yujin Hoshida,Thomas J. Flotte, Gary Della’Zanna,Asad Umar, Kenneth D. Chavin,Sean Cleary,Naoto Kubota,Josep M. Llovet,Tushar Patel,
Gastro Hep Advancesno. 3 (2024): 426-439
引用0浏览0引用
0
0
Kenneth K. Tanabe,David Zahrieh,Carrie A. Strand,Yujin Hoshida,Thomas J. Flotte, Gary Della’Zanna,Asad Umar, Kenneth D. Chavin,Sean Cleary,Naoto Kubota,Josep M. Llovet,Tushar Patel,
Gastro Hep Advances (2024)
FASEB journal : official publication of the Federation of American Societies for Experimental Biologyno. 8 (2024): e23585-e23585
Hepatobiliary Surgery and Nutritionno. 1 (2024): 184-187
Ibrahim Ragab Eissa,Eric D. Abston, Darshini Kuruppu,Yongtao Wang,Guoliang Qiao,Motaz Qadan,Michael Lanuti,Kenneth K. Tanabe
Cancer Researchno. 6_Supplement (2024): 4271-4271
Anand T. N. Kumar,Rahul Pal,Thinzar M. Lwin, Murali N. Krishnamoorthy, Hannah R. Collins,Corey D. Chan, Andrey Prilutskiy,MacLean P. Nasrallah, Tom H. Dijkhuis,Stefan A. Carp, Yin P. Hung,Peter M. Sadow,
Molecular-Guided Surgery: Molecules, Devices, and Applications X (2024)
crossref(2023)
ONCOLOGIST (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn